Advanced treatment in high-grade gliomas.

Gliomas are tumors with high incidence and poor prognosis among primary brain tumors and they present difficulties in surgical removal, having also high recurrence rate. The efficacy of various treatments on high-grade gliomas is not satisfactory. Some studies have found that age, surgery, radiotherapy, chemotherapy and other factors, such as tumor molecular pathology, have a certain impact on the recurrence of high-grade gliomas, and a common concern in the studies of high-grade gliomas is that one single treatment often has low efficacy. However, with the development of molecular biology, there is a deeper understanding of the pathogenesis of these tumors, and molecular targeted therapy has attracked impressive attention. The treatment of recurrent high-grade gliomas is also more abundant , Diversity of treatment options than before. Oncolytic virus therapy, stem cell therapy, immunotherapy and electric field therapy are now available. These emerging treatments are expected to improve the prospect of treating recurrent high-grade gliomas.